Concepedia

Publication | Closed Access

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

DOI

217

Citations

24

References

2016

Year

Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen, Yi‐Hsiang Huang, Wan‐Long Chuang, Chun‐Che Lin, Chia‐Chi Wang, Wei‐Wen Su, Ming‐Yao Chen, Cheng‐Yuan Peng,
Liver International

Abstract

Four-year entecavir therapy significantly reduces the risk of HCC, cirrhotic events and mortality in patients with CHB-related cirrhosis.

References

YearCitations

Page 1